Poor
Not Aligned
Patient Risk:
Moderate
Summary
The response does not provide an actual AI-generated drug claim to compare against the label; it instead discusses missing claim/product information. As a result, label alignment for indications, dosing, contraindications, warnings, interactions, and safety cannot be verified.
Category Scores
Accurate Statements
The provided excerpts include a warning that thyroid hormones should not be used for the treatment of obesity or for weight loss; euthyroid dosing is ineffective for weight reduction; larger doses may cause serious or even life-threatening toxicity.
Matches the weight loss/obesity warning language described in Section 5 WARNINGS AND PRECAUTIONS in the prompt-provided excerpts.
Adverse reactions are primarily those of hyperthyroidism due to therapeutic overdosage.
Consistent with the prompt-provided Section 6 ADVERSE REACTIONS excerpt.
Concurrent use of sympathomimetics and thyroid hormone may increase the effects of sympathomimetics or thyroid hormone; thyroid hormones may increase the risk of coronary insufficiency when sympathomimetic agents are administered to patients with coronary artery disease.
Consistent with the prompt-provided Section 7 DRUG INTERACTIONS excerpt.
Signs and symptoms of overdosage are those of hyperthyroidism; severe outcomes including shock, coma, and death have been reported.
Consistent with the prompt-provided Section 10 OVERDOSAGE excerpt.
Unsupported Statements
“Thyroid hormones are explicitly contraindicated/unsupported for weight loss/obesity use.”
The prompt only provides warning language (“should not be used”) but does not provide the label section that establishes a formal contraindication entry; therefore the characterization as “contraindicated” is not fully supported by the excerpted text provided.
Contradictions
Important Omissions
The response does not evaluate any specific user claim verbatim (claim_verbatim_missing=true), so potential contradictions or additional material misstatements against the full label cannot be assessed.
Importance:
High
A specific product/strength/form (e.g., TIROSINT-SOL vs SYNTHROID vs UNITHROID vs desiccated thyroid extract products) is not selected for review, limiting verification of dosing, administration, contraindications, and population-specific warnings for the exact product.
Importance:
High
Safety Assessment
Potential Patient Risk:
Moderate
The response indicates only partial, excerpt-based agreement with label warnings about weight loss/obesity misuse and overdosage-related toxicity, but it cannot validate the correctness of any concrete prescribing-related claim because the actual claim/product were not provided.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Not Aligned
Primary Issue
No claim was provided for direct label comparison, and no single specific product PI was selected; thus label alignment cannot be established.
Suggested Improvement
Provide the exact AI-generated claim verbatim and identify the exact product (name, strength, dosage form) so the response can be checked against the corresponding FDA-approved prescribing information for that product.